332 related articles for article (PubMed ID: 27187872)
1. Outcomes of intra-detrusor injections of botulinum toxin in patients with spina bifida: A systematic review.
Hascoet J; Manunta A; Brochard C; Arnaud A; Damphousse M; Menard H; Kerdraon J; Journel H; Bonan I; Odent S; Fremond B; Siproudhis L; Gamé X; Peyronnet B;
Neurourol Urodyn; 2017 Mar; 36(3):557-564. PubMed ID: 27187872
[TBL] [Abstract][Full Text] [Related]
2. Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study.
Hascoet J; Peyronnet B; Forin V; Baron M; Capon G; Prudhomme T; Allenet C; Tournier S; Maurin C; Cornu JN; Bouali O; Peycelon M; Arnaud A; Renaux-Petel M; Liard A; Karsenty G; Manunta A; Game X
Urology; 2018 Jun; 116():161-167. PubMed ID: 29522865
[TBL] [Abstract][Full Text] [Related]
3. Intradetrusor Injections of Botulinum Toxin A in Adults with Spinal Dysraphism.
Peyronnet B; Even A; Capon G; De Seze M; Hascoet J; Biardeau X; Baron M; Perrouin-Verbe MA; Boutin JM; Saussine C; Phé V; Lenormand L; Chartier-Kastler E; Cornu JN; Karsenty G; Manunta A; Schurch B; Denys P; Amarenco G; Game X;
J Urol; 2018 Oct; 200(4):875-880. PubMed ID: 29746860
[TBL] [Abstract][Full Text] [Related]
4. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
Leitner L; Guggenbühl-Roy S; Knüpfer SC; Walter M; Schneider MP; Tornic J; Sammer U; Mehnert U; Kessler TM
Eur Urol; 2016 Sep; 70(3):522-8. PubMed ID: 27106070
[TBL] [Abstract][Full Text] [Related]
5. How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity.
Mailho C; Peyronnet B; De Seze M; Even A; Perrouin-Verbe MA; Amarenco G; Chartier-Kastler E; Le Normand L; Manunta A; Karsenty G; Kerdraon J; Ruffion A; Saussine C; Le Breton F; Bernuz B; Castel-Lacanal E; Denys P; Phé V; Gamé X
Neurourol Urodyn; 2024 Apr; 43(4):811-817. PubMed ID: 38451038
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
[TBL] [Abstract][Full Text] [Related]
7. Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?
Kessler TM; Danuser H; Schumacher M; Studer UE; Burkhard FC
Neurourol Urodyn; 2005; 24(3):231-6. PubMed ID: 15747344
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin: a potential alternative to current treatment of neurogenic and idiopathic urinary incontinence due to detrusor overactivity.
Casanova N; McGuire E; Fenner DE
Int J Gynaecol Obstet; 2006 Dec; 95(3):305-11. PubMed ID: 17070528
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of two administration modes of an intra-detrusor injection of 750 units dysport® (abobotulinumtoxinA) in patients suffering from refractory neurogenic detrusor overactivity (NDO): A randomised placebo-controlled phase IIa study.
Denys P; Del Popolo G; Amarenco G; Karsenty G; Le Berre P; Padrazzi B; Picaut P;
Neurourol Urodyn; 2017 Feb; 36(2):457-462. PubMed ID: 26756554
[TBL] [Abstract][Full Text] [Related]
11. Botulinum injection is useless on fibrotic neuropathic bladders.
Tiryaki S; Yagmur I; Parlar Y; Ozel K; Akyildiz C; Avanoglu A; Ulman I
J Pediatr Urol; 2015 Feb; 11(1):27.e1-4. PubMed ID: 25448589
[TBL] [Abstract][Full Text] [Related]
12. Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity.
Hui C; Keji X; Chonghe J; Ping T; Rubiao O; Jianweng Z; Xiangrong D; Liling Z; Maping H; Qingqing L; Qiuling L; Jiebing H; Tanghai H
Spinal Cord; 2016 Jan; 54(1):46-50. PubMed ID: 26261074
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness and safety of sacral neuromodulation on neurogenic bladder and bowel dysfunction in patients with spina bifida].
Chen G; Wang Y; Ying X; Pang D; Liao L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2021 Nov; 35(11):1374-1379. PubMed ID: 34779161
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.
Gamé X; Mouracade P; Chartier-Kastler E; Viehweger E; Moog R; Amarenco G; Denys P; De Seze M; Haab F; Karsenty G; Kerdraon J; Perrouin-Verbe B; Ruffion A; Soler JM; Saussine C
J Pediatr Urol; 2009 Jun; 5(3):156-64. PubMed ID: 19264554
[TBL] [Abstract][Full Text] [Related]
15. Detrusor overactivity in spina bifida: how long does it need to be treated?
Ab E; Dik P; Klijn AJ; van Gool JD; de Jong TP
Neurourol Urodyn; 2004; 23(7):685-8. PubMed ID: 15382196
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.
Karsenty G; Denys P; Amarenco G; De Seze M; Gamé X; Haab F; Kerdraon J; Perrouin-Verbe B; Ruffion A; Saussine C; Soler JM; Schurch B; Chartier-Kastler E
Eur Urol; 2008 Feb; 53(2):275-87. PubMed ID: 17988791
[TBL] [Abstract][Full Text] [Related]
17. Is repeat Botulinum Toxin A injection valuable for neurogenic detrusor overactivity-A systematic review and meta-analysis.
Ni J; Wang X; Cao N; Si J; Gu B
Neurourol Urodyn; 2018 Feb; 37(2):542-553. PubMed ID: 28745818
[TBL] [Abstract][Full Text] [Related]
18. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
Grosse J; Kramer G; Jakse G
BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin for treatment of urinary incontinence due to detrusor overactivity: a systematic review of effectiveness and adverse effects.
MacDonald R; Fink HA; Huckabay C; Monga M; Wilt TJ
Spinal Cord; 2007 Aug; 45(8):535-41. PubMed ID: 17453012
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin therapy for neurogenic detrusor overactivity.
Smaldone MC; Ristau BT; Leng WW
Urol Clin North Am; 2010 Nov; 37(4):567-80. PubMed ID: 20955908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
